TELA Bio, Inc. Operating Income
TELA Bio, Inc. (TELA) reported Operating Income of -$9.28 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-11
- TELA Bio, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$9.28M.
- TELA Bio, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$10.53M.
- TELA Bio, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$6.65M.
- TELA Bio, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$7.55M.
- TELA Bio, Inc. operating income (loss) for fiscal 2025 was -$33.76M.
- TELA Bio, Inc. operating income (loss) for fiscal 2024 was -$34.12M.
- TELA Bio, Inc. operating income (loss) for fiscal 2023 was -$44.08M.
- TELA Bio, Inc. operating income (loss) for fiscal 2022 was -$39.01M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$9.28M 10-Q · filed 2026-08-11 | -$19.81M 10-Q · filed 2026-08-11 | -$26.46M derived: sum of 3 quarters · filed 2026-08-11 | -$34.01M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$10.53M 10-Q · filed 2026-05-13 | -$17.17M derived: sum of 2 quarters · filed 2026-05-13 | -$24.73M derived: sum of 3 quarters · filed 2026-05-13 | -$33.81M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$6.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$14.20M derived: sum of 2 quarters · filed 2026-03-25 | -$23.28M derived: sum of 3 quarters · filed 2026-08-11 | -$33.76M 10-K · filed 2026-03-25 |
| 2025-09-30 | -$7.55M 10-Q · filed 2025-11-14 | -$16.64M derived: sum of 2 quarters · filed 2026-08-11 | -$27.11M 10-Q · filed 2025-11-14 | -$35.46M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$9.08M 10-Q · filed 2026-08-11 | -$19.55M 10-Q · filed 2026-08-11 | -$27.91M derived: sum of 3 quarters · filed 2026-08-11 | -$37.27M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$10.47M 10-Q · filed 2026-05-13 | -$18.83M derived: sum of 2 quarters · filed 2026-05-13 | -$28.19M derived: sum of 3 quarters · filed 2026-05-13 | -$39.76M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$8.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$17.72M derived: sum of 2 quarters · filed 2026-03-25 | -$29.29M derived: sum of 3 quarters · filed 2026-03-25 | -$34.12M 10-K · filed 2026-03-25 |
| 2024-09-30 | -$9.37M 10-Q · filed 2025-11-14 | -$20.93M derived: sum of 2 quarters · filed 2025-11-14 | -$25.76M 10-Q · filed 2025-11-14 | -$38.04M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | -$11.57M 10-Q · filed 2025-08-11 | -$16.40M 10-Q · filed 2025-08-11 | -$28.67M derived: sum of 3 quarters · filed 2026-03-25 | -$38.85M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | -$4.83M 10-Q · filed 2025-05-08 | -$17.10M derived: sum of 2 quarters · filed 2026-03-25 | -$27.29M derived: sum of 3 quarters · filed 2026-03-25 | -$37.65M derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | -$12.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$22.46M derived: sum of 2 quarters · filed 2026-03-25 | -$32.82M derived: sum of 3 quarters · filed 2026-03-25 | -$44.08M 10-K · filed 2026-03-25 |
| 2023-09-30 | -$10.18M 10-Q · filed 2024-11-08 | -$20.54M derived: sum of 2 quarters · filed 2024-11-08 | -$31.80M 10-Q · filed 2024-11-08 | -$41.24M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-06-30 | -$10.36M 10-Q · filed 2024-08-13 | -$21.62M 10-Q · filed 2024-08-13 | -$31.05M derived: sum of 3 quarters · filed 2025-03-21 | -$40.54M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-03-31 | -$11.25M 10-Q · filed 2024-05-10 | -$20.69M derived: sum of 2 quarters · filed 2025-03-21 | -$30.18M derived: sum of 3 quarters · filed 2025-03-21 | -$40.42M derived: sum of 4 quarters · filed 2025-03-21 |
| 2022-12-31 | -$9.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$18.93M derived: sum of 2 quarters · filed 2025-03-21 | -$29.16M derived: sum of 3 quarters · filed 2025-03-21 | -$39.01M 10-K · filed 2025-03-21 |
| 2022-09-30 | -$9.49M 10-Q · filed 2023-11-13 | -$19.72M derived: sum of 2 quarters · filed 2023-11-13 | -$29.57M 10-Q · filed 2023-11-13 | -$37.22M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | -$10.24M 10-Q · filed 2023-08-10 | -$20.08M 10-Q · filed 2023-08-10 | -$27.73M derived: sum of 3 quarters · filed 2024-03-22 | -$34.95M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | -$9.84M 10-Q · filed 2023-05-11 | -$17.50M derived: sum of 2 quarters · filed 2024-03-22 | -$24.71M derived: sum of 3 quarters · filed 2024-03-22 | -$32.03M derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | -$7.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$14.87M derived: sum of 2 quarters · filed 2024-03-22 | -$22.18M derived: sum of 3 quarters · filed 2024-03-22 | -$29.45M 10-K · filed 2024-03-22 |
| 2021-09-30 | -$7.22M 10-Q · filed 2022-11-10 | -$14.53M derived: sum of 2 quarters · filed 2022-11-10 | -$21.80M 10-Q · filed 2022-11-10 | -$28.54M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | -$7.31M 10-Q · filed 2022-08-11 | -$14.58M 10-Q · filed 2022-08-11 | -$21.33M derived: sum of 3 quarters · filed 2023-03-23 | -$28.19M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | -$7.27M 10-Q · filed 2022-05-11 | -$14.02M derived: sum of 2 quarters · filed 2023-03-23 | -$20.88M derived: sum of 3 quarters · filed 2023-03-23 | -$26.05M derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | -$6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$13.61M derived: sum of 2 quarters · filed 2023-03-23 | -$18.78M derived: sum of 3 quarters · filed 2023-03-23 | -$25.27M 10-K · filed 2023-03-23 |
| 2020-09-30 | -$6.86M 10-Q · filed 2021-11-12 | -$12.03M derived: sum of 2 quarters · filed 2021-11-12 | -$18.53M 10-Q · filed 2021-11-12 | -$24.35M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | -$5.17M 10-Q · filed 2021-08-12 | -$11.66M 10-Q · filed 2021-08-12 | -$17.49M derived: sum of 3 quarters · filed 2022-03-23 | -$21.35M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-03-31 | -$6.50M 10-Q · filed 2021-05-14 | -$12.32M derived: sum of 2 quarters · filed 2022-03-23 | -$16.18M derived: sum of 3 quarters · filed 2022-03-23 | -$20.48M derived: sum of 4 quarters · filed 2022-03-23 |
| 2019-12-31 | -$5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$9.68M derived: sum of 2 quarters · filed 2022-03-23 | -$13.98M derived: sum of 3 quarters · filed 2022-03-23 | -$19.16M 10-K · filed 2022-03-23 |
| 2019-09-30 | -$3.86M 10-Q · filed 2020-11-12 | -$8.16M derived: sum of 2 quarters · filed 2020-11-12 | -$13.34M 10-Q · filed 2020-11-12 | -$18.83M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | -$4.30M 10-Q · filed 2020-08-13 | -$9.48M 10-Q · filed 2020-08-13 | -$14.98M derived: sum of 3 quarters · filed 2021-03-25 | -$17.50M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-03-31 | -$5.18M 10-Q · filed 2020-05-15 | -$10.68M derived: sum of 2 quarters · filed 2021-03-25 | -$13.20M derived: sum of 3 quarters · filed 2021-03-25 | |
| 2018-12-31 | -$5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$8.02M derived: sum of 2 quarters · filed 2021-03-25 | -$17.78M 10-K · filed 2021-03-25 | |
| 2018-09-30 | -$2.52M 10-Q · filed 2019-12-18 | -$12.28M 10-Q · filed 2019-12-18 | ||
| 2017-12-31 | -$16.92M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |